The EuroSun project, titled “Quantification of sun exposure in Europe and its effects on health” is an EU funded project (grant n.20065320). This project was financed for the period 2007-2011. This website presents the main results of this project. It will be regularly updated to include future development.
This project involves four teams from European institutes: iPRI, Lyon; INSERM, Lyon; ARMINES, Paris; and Karolinska Institutet, Stockholm.
The International Prevention Research Institute (iPRI) is an independent research institute founded and chaired by Prof.Peter Boyle. iPRI’s mission is to develop various activities aimed at improving the health of populations worldwide, identifying the main problems of detection and disease prevention.
The research of iPRI is mainly focused on the prevention of chronic disease. This work is carried out in collaboration with international partners. A priority of the Institute is to train researchers from low- and medium-resource countries.
iPRI is involved in many international projects of academic research, such as BBMRI, EuroSun and the European Code against Cancer.
Within iPRI, Dr. Mathieu Boniol is biostatistician; devoting his time particularly to the epidemiology of melanoma. He also participates in projects involving various meta-analyses (risk of melanoma, artificial light and skin cancer, vitamin D and cancer). He is also President Elect of EUROSKIN (European Society for Skin Cancer Prevention).
The National Institute of Health and Medical Research (Inserm) is a French public organisation dedicated to medical research, under the joint supervision of the Ministry of Research and Ministry of Health. Inserm, the only French public research body entirely dedicated to human health, has been awarded, in 2008, responsibility for coordinating strategic, scientific and operational leadership in biomedical research. Its mission of coordination has led to the creation of 10 thematic institutes associated with Inserm, in early 2008.
Dr. Jean-François Doré is Emeritus Research Director at INSERM, Unit 590 "Oncogenesis and Tumor Progression" and specialises in the prevention of skin cancer and the extent of exposure to UV radiation. Dr. Doré is currently Chairman of EUROSKIN (European Society for Skin Cancer Prevention).
ARMINES is a contract research organisation where over 90% of the workforce is located in research centres. It manages the activities of the Research “Ecole des mines” in Paris (Mines ParisTech).
The concept of research “orientated” towards the industry is at the base of the creation of ARMINES in 1967. This type of research is based on an exchange between scientists and the industry, it´s neither pure research nor competitive but joint research. Its function is to contribute to the improvement of the technological standard and to the scientists’ progression in their fields of expertise. It´s also the motor for an education by research with, as a consequence, an important annual fluctuation of young scientists turning towards the industry, essential vector of the “transfer” of knowledge and know-how.
ARMINES aims to pool resources to answer questions posed by the economic and social sphere through its realisations to academic missions, research, school training and education.
Within ARMINES, Prof.Lucien Wald is responsible for the group Remote Sensing & Modelling, Center for Energy and Processes, since its founding in 1991. He has supervised doctoral students since 1981 and participates in teaching at the Ecole des Mines de Paris and the University. His activities are generally carried out in French, European or international consortiums.
Karolinska Institutet is one of the world´s leading medical universities, accounts for over 40% of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The university was founded in 1810 by King Karl XIII as an “academy for the training of skilled army surgeons”. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. With a close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.
Within Karolinska Institutet, Prof. Ulrik Ringborg has been conducting research in Oncology since 1992 in the Department of Oncology-Pathology. He has published more than two hundred articles in peer-reviewed journals, nearly half of them on skin cancer in various fields of research including epidemiology and biology, with subject matters ranging from primary prevention to treatment of cutaneous melanomas.